A treatment method for chronic suppurative lacrimal canaliculitis using chalazion forceps.
OBJECTIVE
The purpose of this study is to evaluate the effectiveness of chronic suppurative lacrimal canaliculitis treatment using chalazion forceps.


METHODS
A prospective study was performed on consecutive patients who accepted the aid of chalazion forceps to treat chronic suppurative lacrimal canaliculitis. Two different treatment methods using chalazion forceps were performed according to the degree of lacrimal canaliculitis. Postoperatively, the patients received 0.5% levofloxacin eye drops four times per day and 0.5 g oral levofloxacin tablets once per day for 4 days. The follow-up period was more than 3 months. Lacrimal irrigation, the condition of the lacrimal punctum, and patients' symptoms were carefully evaluated.


RESULTS
In total, 32 patients met the criteria for chronic suppurative lacrimal canaliculitis. Included were 6 males and 26 females. Their average age was 51.7 ± 14.9 years (range; 19-80 years), and all had unilateral canaliculitis. The mean duration of the symptoms was 18.9 ± 9.8 months (range; 3-48 months). The mean follow-up time was 14.7 ± 7.8 months. The signs and symptoms resolved completely in all patients within 15 days, and no recurrence was observed. No patients reported epiphora after the treatment.


CONCLUSIONS
The use of chalazion forceps is effective in treating chronic suppurative lacrimal canaliculitis. The forceps may offer an alternative treatment technology in the management of suppurative lacrimal canaliculitis.
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xiuming
X
Jin
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Fangli
F
Fan
Zhejiang University School of Medicine, Hangzhou, China.
Fan
F
Zhang
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Yingying
Y
Zhao
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Renjian
R
Hu
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000069282:Canaliculitis / Q000601:surgery*; D002908:Chronic Disease; D003475:Curettage; D005260:Female; D006801:Humans; D007440:Intubation / Q000379:methods; D064704:Levofloxacin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013508:Ophthalmologic Surgical Procedures / Q000295:instrumentation*; D011446:Prospective Studies; D013492:Suppuration; D013525:Surgical Instruments; D007507:Therapeutic Irrigation; D055815:Young Adult
D000900:Anti-Bacterial Agents; D064704:Levofloxacin
Ophthal Plast Reconstr Surg. 2014 May-Jun;30(3):229-32
24807537
Ophthal Plast Reconstr Surg. 2009 Nov-Dec;25(6):481-4
19935254
Ophthalmology. 2009 Oct;116(10):2027-30.e2
19616853
Indian J Ophthalmol. 2008 Jul-Aug;56(4):338-40
18580001
Br J Ophthalmol. 1982 Jan;66(1):71-4
7055547
Ophthal Plast Reconstr Surg. 2012 Sep-Oct;28(5):355-60
22836798
Orbit. 2004 Mar;23(1):19-26
15513016
Vet Pathol. 1978 Jul;15(4):506-18
695225
Graefes Arch Clin Exp Ophthalmol. 2007 Jun;245(6):895-7
17120003
Arch Ophthalmol. 1981 Feb;99(2):282-3
7469865
Arch Ophthalmol. 1992 Feb;110(2):200-2
1736867
Ophthalmology. 2006 Oct;113(10):1859.e1-6
16920195
Acta Ophthalmol. 2011 Dec;89(8):759-63
20064116
Ophthal Plast Reconstr Surg. 2008 Jul-Aug;24(4):314-6
18645442
Can J Ophthalmol. 1980 Apr;15(2):73-5
7378898
Orbit. 2014 Oct;33(5):356-8
24831661
Cornea. 1997 May;16(3):377-9
9143816
Ophthalmologica. 1994;208(6):314-7
7845646
J Fr Ophtalmol. 1990;13(3):135-42
2229898